306 jobs
Commercialization Project ManagerNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
201-500 employees
Andreessen Horowitz Founders Fund $254M Series E in 2024 $2.6B valuation
What they do:
Freenome brings accurate and non-invasive disease screening to proactively treat cancer
Personal Healthcare
Biotech
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Director, Compliance, Training & PolicyNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Associate Director/Director Pharmaceutical DevelopmentNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Analytical ScientistNew
51-100 employees
Andreessen Horowitz $80M Series B in 2022
What they do:
Engineering biology to transform drug discovery
Biotech
Quick facts:
📍HQ: Los Angeles, California, USA
51-100 employees
Founded: 2017
Take action:
See who works here 🤝
Check company site 📌
IT Director, Development Business PartnerNew
101-200 employees
Bessemer Post-IPO $2.0B valuation
What they do:
Kymera Therapeutics is pioneering a transformative approach to treating previously untreatable diseases.
Healthcare
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
101-200 employees
Founded: 2016
Take action:
See who works here 🤝
Check company site 📌
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Research Associate II, Analytical Development
51-100 employees
Khosla Ventures $125M Series C in 2021 $99M valuation
What they do:
eGenesis is a life sciences company focused on development and commercialization of engineered organisms for the benefit of human health.
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
51-100 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Environmental, Health, and Safety Specialist
51-100 employees
Khosla Ventures $125M Series C in 2021 $99M valuation
What they do:
eGenesis is a life sciences company focused on development and commercialization of engineered organisms for the benefit of human health.
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
51-100 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Senior Director, Medical Affairs, InternationalNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Director, Business DevelopmentNew
101-200 employees
Bessemer Post-IPO $2.0B valuation
What they do:
Kymera Therapeutics is pioneering a transformative approach to treating previously untreatable diseases.
Healthcare
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
101-200 employees
Founded: 2016
Take action:
See who works here 🤝
Check company site 📌